287 related articles for article (PubMed ID: 23334121)
1. Peritoneal carcinomatosis in patients with ovarian cancer: enhanced CT versus 18F-FDG PET/CT.
Kim HW; Won KS; Zeon SK; Ahn BC; Gayed IW
Clin Nucl Med; 2013 Feb; 38(2):93-7. PubMed ID: 23334121
[TBL] [Abstract][Full Text] [Related]
2. Role of 18F-FDG PET/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca-125.
Rubini G; Altini C; Notaristefano A; Merenda N; Rubini D; Ianora AA; Asabella AN
Rev Esp Med Nucl Imagen Mol; 2014; 33(1):22-7. PubMed ID: 23948509
[TBL] [Abstract][Full Text] [Related]
3. Peritoneal carcinomatosis: role of (18)F-FDG PET.
Turlakow A; Yeung HW; Salmon AS; Macapinlac HA; Larson SM
J Nucl Med; 2003 Sep; 44(9):1407-12. PubMed ID: 12960184
[TBL] [Abstract][Full Text] [Related]
4. [Peritoneal carcinomatosis from ovarian cancer: role of 18F-FDG-PET/CT and CA125].
Rubini G; Altini C; Notaristefano A; Merenda N; Rubini D; Stabile Ianora AA; Giganti M; Niccoli Asabella A
Recenti Prog Med; 2012 Nov; 103(11):510-4. PubMed ID: 23096741
[TBL] [Abstract][Full Text] [Related]
5. Peritoneal carcinomatosis from ovarian cancer: the role of CT and [¹⁸F]FDG-PET/CT.
Funicelli L; Travaini LL; Landoni F; Trifirò G; Bonello L; Bellomi M
Abdom Imaging; 2010 Dec; 35(6):701-7. PubMed ID: 19784697
[TBL] [Abstract][Full Text] [Related]
6. Use of (18)F-FDG PET/CT in the preoperative evaluation of patients diagnosed with peritoneal carcinomatosis of ovarian origin, candidates to cytoreduction and hipec. A pending issue.
Lopez-Lopez V; Cascales-Campos PA; Gil J; Frutos L; Andrade RJ; Fuster-Quiñonero M; Feliciangeli E; Gil E; Parrilla P
Eur J Radiol; 2016 Oct; 85(10):1824-1828. PubMed ID: 27666623
[TBL] [Abstract][Full Text] [Related]
7. Assessment of relapse in patients with peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy using F-18-FDG-PET/CT.
Klumpp B; Schwenzer NF; Gatidis S; Koenigsrainer I; Koenigsrainer A; Beckert S; Mueller M; Claussen CD; Pfannenberg C
Rofo; 2014 Apr; 186(4):359-66. PubMed ID: 24683168
[TBL] [Abstract][Full Text] [Related]
8. Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with 18F-FDG-PET.
Schwenzer NF; Schmidt H; Gatidis S; Brendle C; Müller M; Königsrainer I; Claussen CD; Pfannenberg AC; Schraml C
J Magn Reson Imaging; 2014 Nov; 40(5):1121-8. PubMed ID: 24923481
[TBL] [Abstract][Full Text] [Related]
9. Value of 18F-FDG PET in the detection of peritoneal carcinomatosis.
Suzuki A; Kawano T; Takahashi N; Lee J; Nakagami Y; Miyagi E; Hirahara F; Togo S; Shimada H; Inoue T
Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1413-20. PubMed ID: 15205922
[TBL] [Abstract][Full Text] [Related]
10. Pitfalls and mimickers on (18)F-FDG-PET/CT in peritoneal carcinomatosis from colorectal cancer: An analysis from 37 patients.
Audollent R; Eveno C; Dohan A; Sarda L; Jouvin I; Soyer P; Pocard M
J Visc Surg; 2015 Nov; 152(5):285-91. PubMed ID: 26115889
[TBL] [Abstract][Full Text] [Related]
11. Detection of histologically proven peritoneal carcinomatosis with fused 18F-FDG-PET/MDCT.
Dirisamer A; Schima W; Heinisch M; Weber M; Lehner HP; Haller J; Langsteger W
Eur J Radiol; 2009 Mar; 69(3):536-41. PubMed ID: 18248928
[TBL] [Abstract][Full Text] [Related]
12. High incidence of peritoneal implants in recurrence of intra-abdominal cancer revealed by 18F-FDG PET/CT in patients with increased tumor markers and negative findings on conventional imaging.
Panagiotidis E; Datseris IE; Exarhos D; Skilakaki M; Skoura E; Bamias A
Nucl Med Commun; 2012 Apr; 33(4):431-8. PubMed ID: 22293498
[TBL] [Abstract][Full Text] [Related]
13. FDG-PET/CT in advanced ovarian cancer staging: value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy.
De Iaco P; Musto A; Orazi L; Zamagni C; Rosati M; Allegri V; Cacciari N; Al-Nahhas A; Rubello D; Venturoli S; Fanti S
Eur J Radiol; 2011 Nov; 80(2):e98-103. PubMed ID: 20688446
[TBL] [Abstract][Full Text] [Related]
14. (18)F-FDG-PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Pfannenberg C; Königsrainer I; Aschoff P; Oksüz MO; Zieker D; Beckert S; Symons S; Nieselt K; Glatzle J; Weyhern CV; Brücher BL; Claussen CD; Königsrainer A
Ann Surg Oncol; 2009 May; 16(5):1295-303. PubMed ID: 19252950
[TBL] [Abstract][Full Text] [Related]
15. Peritoneal carcinomatosis in primary ovarian cancer staging: comparison between MDCT, MRI, and 18F-FDG PET/CT.
Schmidt S; Meuli RA; Achtari C; Prior JO
Clin Nucl Med; 2015 May; 40(5):371-7. PubMed ID: 25783507
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography with FDG in the detection of peritoneal and retroperitoneal metastases of ovarian cancer.
Drieskens O; Stroobants S; Gysen M; Vandenbosch G; Mortelmans L; Vergote I
Gynecol Obstet Invest; 2003; 55(3):130-4. PubMed ID: 12865590
[TBL] [Abstract][Full Text] [Related]
17. (18)F-FDG PET/CT, cytoreductive surgery and intraperitoneal chemohyperthermia for the therapeutic management in peritoneal carcinomatosis: A pilot study.
Cistaro A; Cucinotta M; Cassalia L; Priola A; Priola S; Pappalardo M; Coppolino P; De Simone M; Quartuccio N
Rev Esp Med Nucl Imagen Mol; 2016; 35(4):232-7. PubMed ID: 26907833
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of recurrence in gastric carcinoma: Comparison of contrast-enhanced computed tomography and positron emission tomography/computed tomography.
Kim JH; Heo SH; Kim JW; Shin SS; Min JJ; Kwon SY; Jeong YY; Kang HK
World J Gastroenterol; 2017 Sep; 23(35):6448-6456. PubMed ID: 29085194
[TBL] [Abstract][Full Text] [Related]
19. Staging of peritoneal carcinomatosis: enhanced CT vs. PET/CT.
Dromain C; Leboulleux S; Auperin A; Goere D; Malka D; Lumbroso J; Schumberger M; Sigal R; Elias D
Abdom Imaging; 2008; 33(1):87-93. PubMed ID: 17632751
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology.
Castellucci P; Perrone AM; Picchio M; Ghi T; Farsad M; Nanni C; Messa C; Meriggiola MC; Pelusi G; Al-Nahhas A; Rubello D; Fazio F; Fanti S
Nucl Med Commun; 2007 Aug; 28(8):589-95. PubMed ID: 17625380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
